Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evolution of Physical Activity in Severe Asthmatic Patients Treated With Mepolizumab

NCT05404763 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT05404763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05404763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evolution of Physical Activity in Severe Asthmatic Patients Treated With Mepolizumab
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Active, not recruiting
Start date
February 2, 2023
Completion date
August 2, 2026
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, asthma; eosinophilic